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Background: Xiao-Yao-San (XYS) is a Chinese medicinal formula for treating anxiety and depression. This study aims
to evaluate the use of a room-temperature super-extraction system (RTSES) to extract the major active components
of XYS and enhance their psycho-pharmacological effects.
Methods: The neuroprotective roles of XYS/RTSES against reserpine-derived neurotoxicity were evaluated using a
glial cell injury system (in vitro) and a depression-like C57BL/6 J mouse model (in vivo). The anxiolytic-behavioural
effects were measured by the elevated plus-maze (EPM) test and the antidepressant effects were evaluated by the
forced swimming test (FST) and tail suspension test (TST). Glucose tolerance and insulin resistance were assayed by
ELISA. The expression of 5-HT1A receptors in the prefrontal cortex was examined by western blotting.
Results: XYS/RTSES (300 μg/mL) diminished reserpine-induced glial cell death more effectively than either XYS
(300 μg/mL) or fluoxetine (30 μM) at 24 h (P = 0.0481 and P = 0.054, respectively). Oral administration of XYS/RTSES
(500 mg/kg/day) for 4 consecutive weeks significantly elevated the ratios of entries (open arms/closed arms;
P = 0.0177) and shuttle activity (P = 0.00149) on the EPM test, and reduced the immobility time by 90% on the TST
(P = 0.00000538) and FST (P = 0.0000053839). XYS/RTSES also improved the regulation of blood glucose (P = 0.0305)
and increased the insulin sensitivity (P = 0.0093). The Western blot results indicated that the activation of cerebral
5-HT1A receptors may be involved in the mechanisms of XYS/RTSES actions.
Conclusion: The RTSES could provide a novel method for extracting effective anxiolytic- and antidepressant-like
substances. XYS/RTSES improved the regulation of blood glucose and increased the insulin sensitivity in
reserpine-induced anxiety and depression. Neuroprotection of glial cells and activation of cerebral 5-HT1A receptors
were also involved.* Correspondence: jjchuu@mail.stut.edu.tw
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According to WHO, depression is one of the serious dis-
eases of the past century, and will cause health burdens
in 2030 [1], including the development of tension and
mental stress as well as the growing incidence of suicide
[2]. Depression is a severe psychotic disorder that
includes symptoms of depressed mood, sleep disturb-
ance, and psychomotor and body weight abnormalities,
among others [3,4]. Recent studies have shown metabolic
syndrome abnormalities (obesity, glucose intolerance,
hypertension, and hyperlipidemia), that may also be asso-
ciated features of depression [5,6].
The Chinese medicine formula Xiao-Yao-San (XYS) is
a mixture of eight crude drugs (Bupleurum falcatum, An-
gelica sinensis, Paeonia lactiflora, Atractylodes lancea,
Wolfiporia cocos, Zingiber officinale, Mentha arvensis,
and Glycyrrhiza uralensis [6]. Kami-Shoyo-San (KSS), a
herbal formula commonly prescribed for climacteric
symptoms, which is derived from some Chinese herbs
and similar in composition to XYS in a Japanese Kampo
clinic [7,8]. It has been suggested that KSS is a safe and ef-
ficacious therapy for relief of climacteric symptoms in post-
menopausal women [9]. KSS is commonly used to treat
functional dyspepsia, constipation, menopausal symptoms,
premenstrual dysphoric disorder, anti-psychotic-induced
tardive dyskinesia, panic disorder, parkinsonism, insomnia,
and depressive disorders [10-12].
Treatments with XYS had analgesic and antipyretic
effects, increased motor activity with a hedonic effect,
caused significant reversal of stress-induced deficits in
learning and memory in a spatial memory task, and pro-
duced anxiolytic-like effects on the elevated plus-maze
(EPM) test [13,14]. Accordingly, treatments with KSS
significantly lowered the immobility time on the forced
swimming test (FST), improved neurogenesis in the
hippocampus, and induced antidepressant climbing be-
haviour, suggesting that XYS and KSS might be effective
antidepressant agents [15,16]. KSS increased the plasma
tumour necrosis factor-alpha levels in depressed meno-
pausal patients and decreased the interleukin-6 concen-
trations in women with psychological symptoms [10-12].
It also decreased the homocysteine levels and did not
affect the total cholesterol levels in ovariectomized rats
[13]. The social interaction test indicated that KSS
caused its anxiolytic effect through neurosteroid synthesis
followed by gamma-aminobutyric acid/benzodiazepine
receptor stimulations in male mice.
Interestingly, clinical examination of patients with de-
pression revealed a rising prevalence of impaired glucose
tolerance including high fasting blood glucose and ab-
normal oral glucose tolerance test (OGTT) curve, sug-
gesting that the frequency of impaired glucose tolerance
increases with abnormal glycometabolism in patients
with depression [17].Chinese herbal medicine compositions are very com-
plex, and the traditional methods for extracting effective
components have many disadvantages, such as long cycle
processes, insufficient extraction rates and residual or-
ganic solvents [18,19]. To increase the extraction rate,
several novel extraction methods, including cold-soaked
extraction, percolation extraction, reflux extraction,
shattering extraction, continuous-reflux extraction,
ultrahigh-pressure extraction, ultrasonic extraction, and
microwave extraction have been used for effective extrac-
tion of the bioactive components and major ingredients
from Chinese medicinal plants and Chinese herbal
prescriptions [20,21]. The room-temperature super-
extraction system (RTSES) is a novel, organic, solvent-
free extraction technology for ultrasonic extraction of
molecules from solid particles [22]. The system contains
an ultrasound-producing element that produces concen-
trated ultrasonic waves, and acoustic cavities that crush
the particles in the fluid. As a result, large molecules in
the extract retain their activities, and no organic waste
and contaminants are present in the extract or during
the extraction course [23]. In particular, the RTSES has a
higher extraction yield, lower extraction temperature,
and shorter extraction time, involves less power con-
sumption, and preserves the extracts’ bioactivities, mak-
ing it suitable for the extraction of Chinese medicine
components.
It was reported that fluoxetine reduced locomotion in
the C57BL/6 J and 129SvEv mouse strains, but not in
the BALB/c and DBA/2 mouse strains [24]. In the FST,
treatment with fluoxetine (10 and 18 mg/kg/day)
increased swimming and reduced immobility [24]. Later
research showed that the use of inbred C57BL/6 J mice
in a pathological condition and chronic fluoxetine treat-
ment was more accurate for estimating antidepressant
efficiency [25].
The emotional impacts of XYS (conventional water
extraction) and XYS/RTSES (XYS extracted by the
RTSES) were assessed for reserpine-induced anxiety- or
depressive-like behaviours compared with fluoxetine. In
this study, we used the C6 glial cell line, which was
cloned from a rat glioma as a model system, to examine
the neuroprotective roles of XYS/RTSES treatments
against reserpine-mediated injury (in vitro). The anxio-
lytic and antidepressant effects of these treatments in
C57BL/6 J mice were investigated through the EPM, and
the FST and tail-suspension test (TST), respectively. The
oral glucose tolerance and insulin resistance were
assessed to evaluate the influences of the plasma glucose
level and variable insulin sensitivity in reserpine-induced
performance. The expression of 5-hydroxytryptamine 1A
(5-HT1A) receptors in the prefrontal cortex of mice was
measured by western blotting to compare the efficacies
of conventional XYS and XYS/RTSES.
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ing anxiolytic- and antidepressant-like substances from
XYS and to compare the extraction efficacy of the
RTSES with those of other methods.
Methods
XYS prescription
The XYS prescription was composed of eight Chinese
medicinal materials, including B. falcatum (15% w/w), A.
sinensis (15% w/w), P. lactiflora (15% w/w), A. macroce-
phala Koidz (15% w/w), W. cocos (15% w/w), Z. offici-
nale (15% w/w), M. arvensis (6% w/w), and G. uralensis
(4% w/w). These constituents were provided by Sun Ten
Pharmaceutical Co. Ltd. (Taipei, Taiwan). A. macroce-
phala Koidz was used according to Miller-Martini et al.
[12] and Chen et al. [26] instead of A. lancea (Thunb)
[27,28]. The Chinese medicinal materials were pulver-
ized before mixing.
Chemicals and reagents
Minimum essential medium (MEM), foetal bovine
serum, sodium bicarbonate, and 0.05% trypsin-EDTA
were purchased from Gibco Ltd. (USA). Streptozotocin
and fluoxetine were purchased from Sigma (USA).
Mouse monoclonal antibodies against 5-HT1A receptor
and β-actin were purchased from Santa Cruz Biotech-
nology Inc. (USA). Nitrocellulose membranes were pur-
chased from NEN Life Science Products (USA). Mouse
insulin and glucose ELISA kits were purchased from
Mercodia (Sweden).
Preparation procedures for two crude extracts
For conventional water extraction, 1 kg of XYS powder
was suspended in 10 L of double-distilled water and
extracted with hot water by boiling twice for 1.5 h each.
The residues were filtered for in vitro cell toxicity assays.
For the XYS/RTSES procedure, 1 kg of XYS crude pow-
der was suspended in 10 L of pure water and extracted by
the RTSES with an extraction temperature of 20–22°C,
extraction frequency of 40 kHz, and extraction time of
0.5 h [29]. After the extraction, the size of residual pow-
der particles was determined to be 70–300 nm using a
laser particle-size analyser (Zetasizer Nano ZS; Malvern
Instruments, UK). The extracted solutions (XYS and
XYS/RTSES) were vacuum freeze-dried. Unlike the trad-
itional drying, the vacuum freeze-drying process is free
from impurities, and can maintain the original material
components and active ingredients without material
shrinkage or destruction of cells. The dried powders were
dissolved in double-distilled water, and the impurity-free
solutions were stored at −80°C until use. The working
concentration was determined by the initial weight of the
raw materials (g) and the final vehicle volume (mL) after
vacuum freeze-drying. The solutions were provided forin vitro cell toxicity assays and oral administration at 1 h
before the animal tests.
Cell culture
The rat glioma C6 cell line (ATCC# CCL-107) was pur-
chased from the Food Industry Research and Develop-
ment Institute (Taiwan). The cells were maintained in
MEM, containing nonessential amino acids and sodium
pyruvate supplemented with 10% heat-inactivated foetal
bovine serum, 2 mmol/L glutamine, 100 U/mL penicillin
G sodium, and 100 g/mL streptomycin sulfate (Gibco
Laboratories, USA) in 75 T culture flasks. For experi-
ments, the cells were subcultured in microtiter plates in
the above culture medium in an incubator (95% air and
5% CO2 at 37°C), and the medium was changed every
2 days until analysis.
Cell proliferation assay
In vitro cell proliferation assays were performed to
evaluate the effects of XYS (100–300 g/mL), XYS/RTSES
(100–300 g/mL), and fluoxetine (30 M) on the glioma
C6 cell line [30]. Cells at the exponential growth phase
were harvested from the culture flasks by trypsinisation
and suspended in fresh medium to a density of 5 × 104
cells/mL. The cell suspensions were dispensed into 96-
well microplates at 100 L/well and incubated under 5%
CO2 at 37°C. After 24 h, the suspensions were removed,
and 200 L of XYS (100–300 g/mL), XYS/RTSES (100–
300 g/mL), and fluoxetine (30 M) were added, and com-
bined this with pretreatment of reserpine (100 M) at 24
h before exposure. Cell proliferation in the microplates
was determined by the MTT assay (optical density mea-
surements at 570 nm) after 72 h of incubation. The cell
proliferation activity was expressed as the percentage of
MTT counts of treated cells relative to those of control
cells treated with double-distilled water.
Animal experiments
Male C57BL/6 J mice at 4–6 weeks of age (weighing 16–
18 g) were purchased from the National Laboratory Ani-
mal Center (Taiwan). All animals were maintained in
laminar flow cabinets with free access to food and water
under specific pathogen-free conditions in facilities
approved by the Accreditation of Laboratory Animal
Care and in accordance with the Institutional Animal
Care and Use Committee (IACUC) of the Animal Re-
search Committee of the Chi-Mei Medical Center
(Taiwan). The animals were maintained on a daily 12-h/
12-h light/dark cycle, and experiments were carried out
between 10:00 h and 17:00 h. Behavioural stress/depres-
sion was chemically induced by administration of reser-
pine (2 mg/kg/day) for 4 consecutive days. XYS
(500 mg/kg/day), XYS/RTSES (500 mg/kg/day), or fluox-
etine (10 mg/kg/day) was administered orally to the
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(500 mg/kg/day) and XYS/RTSES (500 mg/kg/day) were
two times higher than the maximum recommended
human dose of 250 mg/kg/day based on area under the
curve (AUC) comparisons. Reserpine was administrated
by intraperitoneal injection 30 min before the tests. Drug
solutions were prepared just before the injection and
given in a volume of 0.1 mL for every 10 g body weight
by oral administration and intraperitoneal injection, al-
ternatively. During the experiments, the body weight
was recorded weekly and blood samples were drawn
weekly from the retro-orbital sinus of the mice to moni-
tor the fasting plasma glucose levels. At the end of the
experiments, all mice in the control, fluoxetine, XYS,
and XYS/RTSES groups were euthanized for Western
blotting.
EPM Test
The EPM test was performed as described previously
[31]. The EPM apparatus was constructed from grey
Plexiglas, and consisted of two open arms and two
enclosed arms with 15-cm-high transparent walls, which
were elevated to a height of 55 cm above the floor. A
mouse was placed in the apparatus to start exploring the
maze from the central square of the apparatus (facing an
enclosed arm) for 10 min. The total time spent in the
open and closed arms and the total entries were deter-
mined. For data analysis, the ratio of entries into open
arms to closed arms was analyzed for the evaluation of
anxiolytic activity. Data acquisition and analysis were
performed automatically using Image EP software
(O’Hara & Co., UK).
FST
The FST was performed as described previously [32]. In-
dividual mice were forced to swim in an open cylindrical
container (25-cm height × 10-cm diameter) filled with
water at 24.5–25.5°C up to a height of 10 cm. In our
study, the total duration of immobility was evaluated in
a 10-min swim session in the FST, which was modified
on the basis of a previous study [33]. The mice were
considered immobile when they made only the move-
ments necessary to keep their head above water. The
test was conducted at 1 h after the last drug treatment,
and groups of mice were tested in parallel. Each test was
conducted in a quiet and warm environment. A decrease
in the duration of immobility was indicative of an
antidepressant-like effect.
TST
The TST was performed as described previously [34].
Mice were observed for 6 min, and the cumulative im-
mobility time (latency to immobility, number of immo-
bile segments, and total time spent immobile) during thefinal 5-min interval of the test was recorded. The total
duration of immobility (in seconds) was measured dur-
ing the 5-min period. A decrease in the duration of im-
mobility was indicative of an antidepressant-like effect.
OGTT
After an overnight fast, 3 g/kg of D-glucose was admi-
nistered orally to reserpine-induced mice and saline-
treated control mice. Blood samples were collected from
the tail vein of each mouse at 0, 15, 45, 95, and 135 min
after the start of the oral glucose administration to
measure the fasting blood glucose levels [35].
Insulin tolerance test (ITT)
After an overnight fast, 3 g/kg of D-glucose was admi-
nistered orally after intraperitoneal injection of 0.5 U of
insulin (Sigma-Aldrich, USA) into reserpine-induced
mice and saline-treated control mice. The blood samples
were collected from the tail vein of each mouse at 0, 15,
45, 95, and 135 min after the oral glucose administration
to measure the fasting blood glucose levels [36]. For the
ITT, the percentage decrease in blood glucose from the
0-min time point was calculated.
Western blotting
At the end of the experiments, the mice in each group
were euthanized, and the cerebrum was removed for
analysis of the expression levels of depression-like rele-
vant proteins [37]. The cerebrum was prepared in lysis
buffer (1% NP-40, 150 mM NaCl, 20 mM Tris–HCl pH
7.5, and protease inhibitors). After incubation on ice for
30 min, the lysates were centrifuged (Centrifuge 5804R;
Eppendorf Co. Ltd., USA) at 13,000 × g for 30 min.
Post-nuclear supernatants were mixed with equal
volumes of 2× sample buffer (12.5 mm Tris–HCl pH
6.8, 2% SDS, 20% glycerol, and 0.25% bromophenol blue)
and boiled for 5 min. The samples were separated in
10% polyacrylamide gels, and then transferred to nitro-
cellulose membranes. The membranes were blocked
with bovine serum albumin in 0.1 M phosphate buffer
saline with Tween, containing 0.2 M Na2HPO4, 0.2 M
NaH2PO4, 1.5 M NaCl and 0.1% Tween 20 for 2 h at
room temperature. After blocking, the membranes were
incubated with the anti-5-HT1A antibody diluted 1:500
in wash buffer for 1 h at room temperature, followed by
four 10-min washes. The membranes were then incu-
bated with a horseradish peroxidase-conjugated anti-
rabbit IgG antibody diluted 1:5,000 in wash buffer for 1 h
at room temperature, Horseradish peroxidase was added
to visualize antibody-bound target protein on the nitro-
cellulose membrane. Western blot images were obtained
using a LAS-3000 analyzer (FUJIFILM LAS-3000; Fuji
Photo Film Co. Ltd., Japan). The signals for β-actin were
also evaluated to normalize the protein loading.
Figure 1 Cell viability and neuroprotection against
reserpine-induced injury. (A–C) Using the MTT cell proliferation
assay, fluoxetine and different concentrations of XYS and XYS/RTSES
were evaluated for cell proliferation (A). Various concentrations of
reserpine were evaluated for damage to glial cells (B). Pretreatment
with reserpine (100 M) at 24 h followed by treatment with
fluoxetine, XYS, and XYS/RTSES (C) on the glioma C6 cell line after
incubation for 24 and 72 h is shown. Each value is expressed as the
mean ± SD of three culture wells. *P < 0.05, **P < 0.01, ***P < 0.001,
significant difference compared with control C6 cells. #P < 0.05,
##P < 0.01, ###P < 0.001, significantly difference compared with
XYS alone.
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All results were presented as the mean ± standard devi-
ation (SD). Differences between groups were evaluated
by analysis of variance and post-hoc comparisons with
the Bonferroni step-down (Holm) correction. All ana-
lyses were conducted using Sigma Plot software (version
10.0; SPSS Inc., USA). The dose-dependent relationships




In the MTT assay, fluoxetine (30 μM) slightly stimulated
the cell growth at 24 h (P = 0.034) and 72 h (P = 0.0479),
while XYS and XYS/RTSES showed dose-dependent
enhancing effects on the cell proliferation at 72 h
(Figure 1A). Reserpine (100 and 150 M) severely affected
the cell growth (> 90%) at 24 h (P = 0.0012) and 72 h
(P = 0.0000097) (Figure 1B). When combined with pre-
treatment of reserpine (100 M), XYS/RTSES (300 μg/
mL) prevented reserpine-induced injury at 24 h (P =
0.0274), while XYS did not (Figure 1C), demonstrating
that XYS/RTSES improved the neurological function.
Anxiolytic- and antidepressant-like effects
In the EPM test, reserpine (2 mg/kg/day) increased the
time spent in the open arms and decreased the time
spent in the closed arms after administration for 4 con-
secutive days, giving smaller ratios of entries onto open
arms to closed arms than the control group at 2 weeks
(P = 0.00008037) (Figure 2A) and 4 weeks (P = 0.000029)
(Figure 2C). Accordingly, oral administration of XYS/
RTSES for 2 consecutive weeks (P = 0.037) or 4 consecu-
tive weeks (P = 0.05) elevated the ratios of entries onto
open arms to closed arms, compared with the same
treatment (500 mg/kg/day) of XYS (P = 0.018)
(Figure 2B). The XYS/RTSES (500 mg/kg/day) group
showed reduced locomotor activity (P = 0.000102) and
no significant difference compared with the normal con-
trol mice at 4 weeks (P = 0.5565) (Figure 2D). These
findings suggest that XYS/RTSES may reduce reserpine-
induced anxiety in mice.
The effects of XYS (500 mg/kg/day, peroral) or XYS/
RTSES (500 mg/kg/day, peroral), in combination with
reserpine (2 mg/kg/day, intraperitoneal) pretreatment,
on the total duration of immobility in mice were evalu-
ated at 4 weeks by the FST (Figure 3A) and TST
(Figure 3B). In the FST, our data indicated that adminis-
tration of XYS/RTSES significantly reduced the immo-
bility time by 90% (P = 0.000002486), while fluoxetine
and XYS reduced the immobility time by 75% (P =
0.001157) and 50% (P = 0.000437), respectively
(Figure 3A). Similar effects were observed in the TST
(Figure 3B).
Figure 2 Anxiety behaviour in the EPM test. C57BL/6 J mice
(N = 8) completed the EPM test. The time spent (in seconds) in the
open arms and closed arms during the 10-min test period was
evaluated. After treatment with fluoxetine, XYS, and XYS/RTSES,
the ratios of entries onto open arms to closed arms were calculated
at 2 weeks (A) and 4 weeks (B), respectively. The numbers of total
entries (crossing between open and closed arms) were recorded
at 2 weeks (C) and 4 weeks (D). Each value is expressed as the
mean ± SD of 8 mice. *P < 0.05, **P < 0.01, ***P < 0.001, significant
difference compared with control C57BL/6 J mice. #P < 0.05, ##P < 0.01,
###P < 0.001, significant difference compared with XYS alone.
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consecutive days, the treatments with XYS/RTSES, XYS,
and fluoxetine were administered. The OGTT was mon-
itored for 4 weeks. The fasting blood glucose levels were
reduced in the 4 weeks reserpine-treated group in time-
intervals (0 min: P = 0.02; 15 min: P = 0.06; 48 min: P =
0.341; 95 min: P = 0.78; 135 min: P = 0.0105) compared
with the control group. The normal glucose tolerance
curve did not show any significant differences compared
with the control group throughout the study period after
the administration of XYS/RTSES for 4 consecutive
weeks. Neither XYS nor fluoxetine could reverse the
reserpine-induced hypoglycaemia (Figure 4A).
The ITT was performed to evaluate glucose tolerance
in depression induced by reserpine. After 4 weeks of
treatment, the blood glucose levels were decreased in the
XYS-treated (P = 0.22), XYS/RTSES-treated (P = 0.0066),
and fluoxetine-treated (P = 0.013) groups compared with
the reserpine-treated group (Figure 4B). The combined
results from the OGTT and ITT suggest that XYS/RTSES
increases the insulin sensitivity in reserpine-induced
depression.
Expression of 5-HT1A receptors
A marked decrease in cerebral 5-HT1A receptor expres-
sion was observed in the reserpine-treated group com-
pared with the control group (P = 0.00084). The
administration of XYS/RTSES for 4 consecutive weeks
elevated the 5-HT1A receptor expression (P = 0.0047)
compared with administration of XYS or fluoxetine
(Figure 5A), suggesting that the decreased 5-HT1A re-
ceptor activity returned toward the basal level after
XYS/RTSES treatment.
Discussion
In this study, we established a reserpine-induced injury
glial cell system and a depression-like mouse model to
investigate the neuroprotective roles of XYS and XYS/
RTSES treatments in vitro and in vivo. We strengthened
the research of XYS for preclinical studies by reinforcing
the extraction of the major active components and
evaluating the potential pharmacological effects in an
animal behavioural model through the RTSES.
Figure 3 Depressive-like behaviour. Studies were conducted in
C57BL/6 J mice (N = 8). After 4 weeks of treatment with fluoxetine,
XYS, and XYS/RTSES, the total duration of immobility (in seconds)
in the mice was measured on the FST (A) and TST (B). Each value
is expressed as the mean ± SD of 8 mice. *P < 0.05, **P < 0.01,
***P < 0.001, significant difference compared with control
C57BL/6 J mice. #P < 0.05, ##P < 0.01, ###P < 0.001, significant
difference compared with XYS alone.
Figure 4 Insulin and glucose dynamics. C57BL/6 J mice (N = 8)
were evaluated and compared for insulin secretion. After 4 weeks
of treatment with fluoxetine, XYS, and XYS/RTSES, the OGTT was
performed for the regulation of plasma glucose (A) and the ITT was
performed for the plasma glucose response (B) after fasting for 16 h.
Each value is expressed as the mean ± SD of 8 mice. *P < 0.05,
**P < 0.01, ***P < 0.001, significant difference compared with control
C57BL/6 J mice. #P < 0.05, ##P < 0.01, ###P < 0.001, significant
difference compared with XYS alone.
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enhancing effect on cell proliferation. XYS/RTSES
revealed partial neuroprotection compared with XYS.
These data suggested that XYS/RTSES plays a pivotal
role in controlling C6 glial cells and protects neurons
against reserpine-induced oxidative stress, which is con-
sistent with previous studies [38,39] that the release of
glial cell line-derived neurotrophic factor from glial cells
is a consequence of extracellular signal-regulated kinase/
mitogen-activated protein kinase signalling activation by
norquetiapine, which may contribute to the putative
antidepressant properties of quetiapine.
In the EPM test, we found that oral administration of
XYS/RTSES (500 mg/kg/day) for 2 consecutive weeks
elevated the ratios of entries onto open arms to closed
arms, compared with the same treatment with XYS
(500 mg/kg/day) or fluoxetine (10 mg/kg/day). Mean-
while, XYS/RTSES also reversed the reduction in total
entries in the reserpine-induced hypokinesia. However,the anxiolytic effects of XYS and fluoxetine were mostly
blocked by reserpine pretreatment.
Some studies have identified that reserpine-induced
hypokinesia was not reversed by either caffeine or tri-
hexyphenidyl, which is a drug commonly used to reduce
Parkinsonian symptoms [40,41]. Interestingly, fluoxetine
has been demonstrated to increase activity levels and re-
duce immobility time in the FST, but decrease open-arm
exploration in the EPM [38]. A similar study showed
that treatment with fluoxetine (5-HT transporter)
throughout mouse adolescence (3–7 weeks of age) did
not produce detectable lasting abnormalities in either
high-anxiety or low-anxiety inbred C57BL/6 J mouse
strains [42]. These results suggest that XYS/RTSES
could be a potential and prominent anxiolytic-like agent.
Our FST and TST data demonstrated that XYS/RTSES
administration significantly reduced the immobility time
Figure 5 Improvement of 5-HT1A receptor expression in the
cerebrum. (A) After 4 weeks of treatment with fluoxetine, XYS and
XYS/RTSES, the 5-HT1A receptor expression levels in C57BL/6 mice
(N = 8) were detected by western blot analysis. (B) The β-actin levels
were evaluated as a loading control, and the data are expressed as
the 5-HT1A protein/β-actin ratios (B). Each value is expressed as the
mean ± SD of 8 mice. *P < 0.05, **P < 0.01, ***P < 0.001, significant
difference compared with control C57BL/6 J mice. #P < 0.05, ##P < 0.01,
###P < 0.001, significant difference compared with XYS alone.
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ity time by 75% and 50%, respectively. The combined
results suggest that XYS/RTSES may have anxiolytic-
and antidepressant-like properties.
Consistently, rosiglitazone normalized hyperglycaemia,
improved glucose tolerance, and significantly reduced the
immobility time in the FST in db/db mice, suggesting an
antidepressant-like effect [38,43]. Related studies demon-
strated that 1 week of insulin treatment at 0.1 IU/g/day
partially antagonized these depressive-like behaviours of
streptozotocin-diabetic mice [44], while treatment with in-
sulin at 1.0 IU/kg had a significant enhancing effect on the
percentage of open-arm duration in anxious mice [45]. In
accordance with these findings, XYS/RTSES improved the
regulation of blood glucose and increased the insulin sensi-
tivity in reserpine-induced glucose intolerance in mice, indi-
cating that the antidepressant effect of XYS/RTSES may be
partially caused by improvement of the reserpine-induced
glucose intolerance.
Our OGTT data revealed that reserpine reduced the
fasting blood glucose level at all time points (0–135
min). However, administration of XYS/RTSES for 4 con-
secutive weeks retained the glucose tolerance, while nei-
ther XYS nor fluoxetine reversed the reserpine-induced
hypoglycaemia. 5-HT1A receptor activation has been
shown to increase dopamine release. As a potential
mechanism, XYS/RTSES might increase the expression
of 5-HT1A receptor, and then the activation of D2 dopa-
mine receptor induced a dose-related increase of plasmaglucagons [46]. The ITT indicated that XYS/RTSES had
an obvious effect on the variation in insulin sensitivity.
Our results are consistent with previous studies demon-
strating that 1 week of treatment with insulin at 0.1 IU/
g/day partially antagonized these depressive-like beha-
viours in streptozotocin-diabetic mice on the Porsolt
swim test [47], while treatment with insulin at 1.0 IU/kg
significantly enhanced the effect on the percentage of
open-arm duration in anxious mice on the EPM [48]. In
accordance with these findings, XYS/RTSES improved
the regulation of blood glucose and increased the insulin
sensitivity in the reserpine-induced glucose intolerance
in mice, indicating that the antidepressant effect of XYS/
RTSES may be partially caused by the improvement in
glucose intolerance.
Our results showed that reserpine decreased the 5-
HT1A receptor activity in the cerebrum, and confirmed
that XYS/RTSES had antidepressant-like effects similar
to typical antidepressants that were mediated by 5-HT1A
receptors. Our Western blotting data suggested the acti-
vation of cerebral 5-HT1A receptors was responsible for
the anxiolytic and antidepressant actions after XYS/
RTSES treatment.
The action mechanisms of the anxiolytic- and
antidepressant-like behavioural effects could be at least
partly caused by the protection against reserpine-
induced C6 glial cell damage and augmentation of the
activation of cerebral 5-HT1A receptors in reserpine-
induced depressant-like mice.
The RTSES is simple, feasible, efficient, and suitable
for highly valuable Chinese herbal medicines. Recent re-
search has also shown that ultrasound-assisted extrac-
tion of the common Chinese herbal prescription Xiao-
chai-hu-tang is feasible for replacing the traditional,
time-consuming, and low-efficiency preparation proce-
dures, and produces the highest bioactive constituent
concentrations and best antioxidant functionalities [24].Conclusion
The XYS/RTSES significantly elevated the shuttle activ-
ity, reduced the immobility time on TST and FST, also
improved the regulation of blood glucose and increased
the insulin sensitivity in reserpine-induced anxiety and
depression in mice. The activation of cerebral 5-HT1A
receptors and neuroprotection of glial cells may be
involved in the mechanisms of XYS/RTSES actions.
RTSES could provide a novel method for extracting the
anxiolytic- and antidepressant-like substances from XYS.Abbreviations
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glucose tolerance test; ITT: Insulin tolerance test.
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